Health and Pharmacoeconomics for biotech CEOs

Yali Friedman, the author of "Building biotech" and editor of http://www.biotechblog.com/ is writing his new book for biotech executies. Stephen Russell, a business partner, and myself are contributing a chapter called "Maximizing the strategic impact of health- and pharmacoeconomics in biotechnology companies." We are looking forward to Yali's new book. Watch out his blog for more news...

No comments: